P3 Health Partners Announces Third Quarter 2026 Results
Business Wire•09/11/2026•16:05 ET
0
Key Highlights
- ➤Q3 revenue $396 million, up 15% year over year
- ➤Q3 net income $30.8 million versus $69.5 million loss
- ➤Q3 Adjusted EBITDA $20.9 million versus $45.9 million loss
- ➤2026 Adjusted EBITDA guidance raised to $90 million-$110 million
- ➤At-risk membership approximately 105,000, down 9% year over year
Expert Statements
Dr. Aric Coffman, CEO of P3 Health Partners
“This was another strong quarter for P3. The foundation we have built over the past two years is showing up both in the care our patients receive and in the consistency of our results. We carry real momentum into 2027, as evidenced by our medical cost trend, and I am excited about what lies ahead for our patients, our providers, and our partners,”
Adjusted EBITDA of $21 Million for the Third Quarter and $101 Million Year-to-Date
Management to Host Conference Call and Webcast November 9, 2026 at 4:30 PM ET
Get started
Create a free account to read the full story.